LGHT ETF Holdings

Holdings

Symbol	Grade	Price % Change	Allocation
ISRG	A	1.33	15.39
GEHC	C	-3.11	8.56
RMD	C	0.08	6.71
IQV	F	0.45	6.34
DXCM	C	0.01	5.51
PODD	B	-0.55	5.26
VEEV	C	1.43	5.15
PHG	C	-0.38	4.87
ZBH	C	-0.12	3.57
BNTX	D	1.64	3.53
ALGN	D	0.93	2.85
MASI	B	1.71	2.46
DOCS	C	-1.78	2.06
MRNA	F	-0.46	1.72
PRCT	B	1.39	1.27
ALKS	C	-0.72	0.66
TNDM	D	4.64	0.54
IRTC	C	0.41	0.44
PRVA	C	-0.58	0.44
OMCL	C	2.87	0.42
LFST	C	0.07	0.31
TDOC	C	7.71	0.28
PGNY	F	3.51	0.25
EVH	F	-0.88	0.22
SDGR	C	1.23	0.21
GDRX	F	-1.51	0.20
ALHC	C	-1.00	0.20
PHR	F	-0.54	0.17
ACCD	F	0.21	0.07
MODV	C	0.00	0.03
TBRG	A	-2.66	0.03

Represented by ETF Holdings

Keywords: Medicine Telemedicine S&P 500 Telehealth Nasdaq 100 Diabetes Health Informatics Diabetes Mellitus Endocrine System Endocrinology Glucose Healthcare Providers Life Sciences Medical Equipment Surgery Clinical Medicine Dentist Diabetes Management Disease Drug Discovery

Industries: Health Information Services Health Information Services Medical Devices Medical Instruments & Supplies Biotechnology Diagnostics & Research Healthcare Plans Medical Care Medical Care Facilities

Recent News for Langar Global HealthTech ETF & its Holdings

Date	Stock	Title
Nov 21	MRNA	Major companies that are also popular short-selling stocks
Nov 21	RMD	This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Nov 21	SDGR	Schrödinger: Positive Signs Despite The Share Price Decline
Nov 21	RMD	HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
Nov 21	VEEV	Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
Nov 21	GEHC	GE HealthCare reiterates annual outlook, lifts dividend
Nov 21	GEHC	GE HealthCare Technologies raises dividend to $0.035/share
Nov 21	GEHC	GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
Nov 21	VEEV	Veeva on supporting the data burden in the life sciences sector
Nov 21	PHG	Philips unveils next-generation BlueSeal helium-free MRI system, integrated with AI-enabled Smart Reading at #RSNA24
Nov 20	PODD	Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Nov 20	IRTC	iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
Nov 20	ALGN	Align Technology Has Received CE Mark in Europe for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients, Including Teenage Patients
Nov 20	MRNA	CDC warns of an imminent spike in COVID, flu cases
Nov 20	RMD	3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD)
Nov 20	ALHC	Health insurers spike as Trump picks Dr. Oz to head Medicare
Nov 20	PODD	Insulet's Omnipod 5 now compatible with Abbott's FreeStyle Libre 2 Plus
Nov 20	SDGR	Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Nov 20	PODD	Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
Nov 20	RMD	Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.

ETF Components for LGHT - Langar Global HealthTech ETF